Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, Nevada.
Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, Nevada
Am J Physiol Cell Physiol. 2014 Sep 15;307(6):C561-70. doi: 10.1152/ajpcell.00080.2014. Epub 2014 Jul 23.
Enteric inhibitory neurotransmission is an important feature of the neural regulation of gastrointestinal motility. Purinergic neurotransmission, via P2Y1 receptors, mediates one phase of inhibitory neural control. For decades, ATP has been assumed to be the purinergic neurotransmitter and smooth muscle cells (SMCs) have been considered the primary targets for inhibitory neurotransmission. Recent experiments have cast doubt on both of these assumptions and suggested that another cell type, platelet-derived growth factor receptor-α-positive (PDGFRα(+)) cells, is the target for purinergic neurotransmission. We compared responses of PDGFRα(+) cells and SMCs to several purine compounds to determine if these cells responded in a manner consistent with enteric inhibitory neurotransmission. ATP hyperpolarized PDGFRα(+) cells but depolarized SMCs. Only part of the ATP response in PDGFRα(+) cells was blocked by MRS 2500, a P2Y1 antagonist. ADP, MRS 2365, β-NAD, and adenosine 5-diphosphate-ribose, P2Y1 agonists, hyperpolarized PDGFRα(+) cells, and these responses were blocked by MRS 2500. Adenosine 5-diphosphate-ribose was more potent in eliciting hyperpolarization responses than β-NAD. P2Y1 agonists failed to elicit responses in SMCs. Small hyperpolarization responses were elicited in SMCs by a small-conductance Ca(2+)-activated K(+) channel agonist, cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine, consistent with the low expression and current density of small-conductance Ca(2+)-activated K(+) channels in these cells. Large-amplitude hyperpolarization responses, elicited in PDGFRα(+) cells, but not SMCs, by P2Y1 agonists are consistent with the generation of inhibitory junction potentials in intact muscles in response to purinergic neurotransmission. The responses of PDGFRα(+) cells and SMCs to purines suggest that SMCs are unlikely targets for purinergic neurotransmission in colonic muscles.
肠抑制性神经传递是胃肠道运动神经调节的一个重要特征。嘌呤能神经传递通过 P2Y1 受体介导抑制性神经控制的一个阶段。几十年来,人们一直认为 ATP 是嘌呤能神经递质,平滑肌细胞(SMCs)被认为是抑制性神经传递的主要靶点。最近的实验对这两个假设提出了质疑,并表明另一种细胞类型,血小板衍生生长因子受体-α阳性(PDGFRα(+))细胞,是嘌呤能神经递质的靶点。我们比较了 PDGFRα(+)细胞和 SMC 对几种嘌呤化合物的反应,以确定这些细胞的反应是否与肠抑制性神经传递一致。ATP 使 PDGFRα(+)细胞超极化,但使 SMC 去极化。PDGFRα(+)细胞中 ATP 反应的一部分仅被 P2Y1 拮抗剂 MRS 2500 阻断。ADP、MRS 2365、β-NAD 和腺苷 5-二磷酸核糖,P2Y1 激动剂,使 PDGFRα(+)细胞超极化,这些反应被 MRS 2500 阻断。与 β-NAD 相比,腺苷 5-二磷酸核糖更能引发超极化反应。P2Y1 激动剂不能在 SMC 中引发反应。小电导钙激活钾(BK)通道激动剂环已基-[2-(3,5-二甲基-吡唑-1-基)-6-甲基-嘧啶-4-基]-胺在 SMC 中引起小的超极化反应,这与这些细胞中 BK 通道的低表达和电流密度一致。P2Y1 激动剂在 PDGFRα(+)细胞中引起大振幅超极化反应,但在 SMC 中没有引起反应,这与完整肌肉中对嘌呤能神经传递的抑制性接头电位的产生一致。PDGFRα(+)细胞和 SMC 对嘌呤的反应表明,SMC 不太可能成为结肠肌肉中嘌呤能神经传递的靶点。